Sang Hoon Joo

Dr. Sang Hoon Joo

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
SJSang Hoon Joo
Sang Hoon Joo
There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. Encouraged by natural cyclic peptides with biological activity, efforts have been made to develop cyclic peptides with both genetic and synthetic methods. The genetic methods include phage display, intein-based cyclic peptides, and mRNA display. The synthetic methods involve individual synthesis, parallel synthesis, as well as split-and-pool synthesis. Recent development of cyclic peptide library based on split-and-pool synthesis allows on-bead screening, in-solution screening, and microarray screening of cyclic peptides for biological activity. Cyclic peptides will be useful as receptor agonist/antagonist, RNA binding molecule, enzyme inhibitor and so on, and more cyclic peptides will emerge as therapeutic agents and biochemical tools.

30 March 2016 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
CJChul-Ho Jeong
Chul-Ho Jeong
SJSang Hoon Joo
Sang Hoon Joo
Chul-Ho Jeong, and Sang Hoon Joo. J Cancer Prev 2016;21:13-20. https://doi.org/10.15430/JCP.2016.21.1.13

1 January 2020 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
JCJoon-Seok Choi
Joon-Seok Choi
SJSang Hoon Joo
Sang Hoon Joo
Notable progress has been made in the therapeutic and research applications of cyclic peptides since our previous review. New drugs based on cyclic peptides are entering the market, such as plecanatide, a cyclic peptide approved by the United States Food and Drug Administration in 2017 for the treatment of chronic idiopathic constipation. In this review, we discuss recent developments in stapled peptides, prepared with the use of chemical linkers, and bicyclic/tricyclic peptides with more than two rings. These have widespread applications for clinical and research purposes: imaging, diagnostics, improvement of oral absorption, enzyme inhibition, development of receptor agonist/antagonist, and the modulation of protein-protein interaction or protein-RNA interaction. Many cyclic peptides are expected to emerge as therapeutics and biochemical tools.

20 April 2022 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
PDF file
KCKyung-Soo Chun
Kyung-Soo Chun
SJSang Hoon Joo
Sang Hoon Joo
Kyung-Soo Chun and Sang Hoon Joo. Biomolecules & Therapeutics 2022;30:479-89. https://doi.org/10.4062/biomolther.2022.017

1 October 2019 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
JPJi Eun Park
Ji Eun Park
DKDo-Hee Kim
Do-Hee Kim
EHEunyoung Ha
Eunyoung Ha
SCSeung Mi Choi
Seung Mi Choi
JCJoon-Seok Choi
Joon-Seok Choi
SJSang Hoon Joo
Sang Hoon Joo

1 November 2015 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
SJSang Hoon Joo
Sang Hoon Joo
In this review, lipid A, from its discovery to recent findings, is presented as a drug target and therapeutic molecule. First, the biosynthetic pathway for lipid A, the Raetz pathway, serves as a good drug target for antibiotic development. Several assay methods used to screen for inhibitors of lipid A synthesis will be presented, and some of the promising lead compounds will be described. Second, utilization of lipid A biosynthetic pathways by various bacterial species can generate modified lipid A molecules with therapeutic value.